{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:02:49Z","timestamp":1790427769228,"version":"4.1.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007610","name":"Vlaamse Instelling voor Technologisch Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00595","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T04:17:35Z","timestamp":1594786655000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective"],"prefix":"10.3389","volume":"11","author":[{"given":"Yannick","family":"Vermeiren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Hirschberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"De Deyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/ejn.14269","article-title":"The prodromes of Parkinson's disease","volume":"49","author":"Rees","year":"2019","journal-title":"Eur J Neurosci."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"38","author":"Ehringer","year":"1960","journal-title":"Wien Klin Wochenschr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.1971.03190260019005","article-title":"Levodopa in the treatment of Parkinsonism","volume":"218","author":"Cotzias","year":"1971","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10286-010-0065-7","article-title":"Catecholamines 101","volume":"20","author":"Goldstein","year":"2010","journal-title":"Clin Auton Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2377-11-88","article-title":"Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease","volume":"11","author":"Isaias","year":"2011","journal-title":"BMC Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/jnc.12766","article-title":"A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease","volume":"131","author":"Goldstein","year":"2014","journal-title":"J Neurochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainres.2017.09.033","article-title":"The heart of PD: lewy body diseases as neurocardiologic disorders","volume":"1702","author":"Goldstein","year":"2019","journal-title":"Brain Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging."},{"key":"B11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.24921","article-title":"Lewy pathology and neurodegeneration in premotor Parkinson's disease","volume":"27","author":"Del Tredici","year":"2012","journal-title":"Mov Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/01.HYP.11.6.602","article-title":"Role of the nucleus ambiguus in the regulation of heart rate and arterial pressure","volume":"11","author":"Machado","year":"1988","journal-title":"Hypertension."},{"key":"B13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.parkreldis.2009.01.008","article-title":"Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease","volume":"15","author":"Kim","year":"2009","journal-title":"Parkinsonism Relat Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/mds.23127","article-title":"Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease","volume":"25","author":"Nakamura","year":"2010","journal-title":"Mov Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/mds.23744","article-title":"Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?","volume":"26","author":"Nakamura","year":"2011","journal-title":"Mov Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein","year":"2008","journal-title":"Parkinsonism Relat Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2016.01.020","article-title":"Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder","volume":"15","author":"Kim","year":"2016","journal-title":"J Neurol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/mds.21581","article-title":"Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations","volume":"22","author":"Oka","year":"2007","journal-title":"Mov Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00415-018-9104-4","article-title":"Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study","volume":"266","author":"Romagnolo","year":"2019","journal-title":"J Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1212\/WNL.0000000000002086","article-title":"Survival in synucleinopathies: a prospective cohort study","volume":"85","author":"Goldstein","year":"2015","journal-title":"Neurology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/mds.870060211","article-title":"Gastrointestinal symptoms in Parkinson's disease","volume":"6","author":"Edwards","year":"1991","journal-title":"Mov Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson's disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-009-0596-y","article-title":"Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study","volume":"118","author":"Ghebremedhin","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e130441","DOI":"10.1172\/jci.insight.130441","article-title":"Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in lewy body diseases","volume":"4","author":"Goldstein","year":"2019","journal-title":"JCI Insight."},{"key":"B25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1196\/annals.1410.066","article-title":"Attenuated pre-ejection period response to tyramine in patients with cardiac sympathetic denervation","volume":"1148","author":"Imrich","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/01.wnl.0000219640.59984.a7","article-title":"Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD","volume":"66","author":"Yoshita","year":"2006","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jns.2011.04.011","article-title":"Autonomic dysfunction in PD: a window to early detection?","volume":"310","author":"Goldstein","year":"2011","journal-title":"J Neurol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2051-5960-1-2","article-title":"The prion hypothesis in Parkinson's disease: braak to the future","volume":"1","author":"Visanji","year":"2013","journal-title":"Acta Neuropathol Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2016.10.008","article-title":"The threshold theory for Parkinson's disease","volume":"40","author":"Engelender","year":"2017","journal-title":"Trends Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/ana.24531","article-title":"Does vagotomy reduce the risk of Parkinson's disease?","volume":"78","author":"Tysnes","year":"2015","journal-title":"Ann Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.20226","article-title":"Parkinsonian signs and substantia nigra neuron density in decendents elders without PD","volume":"56","author":"Ross","year":"2004","journal-title":"Ann Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pharmthera.2014.06.006","article-title":"Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders","volume":"144","author":"Goldstein","year":"2014","journal-title":"Pharmacol Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(01)00120-6","article-title":"3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis","volume":"93","author":"Li","year":"2001","journal-title":"Brain Res Mol Brain Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1172\/JCI130513","article-title":"Norepinephrine metabolite DOPEGAL activates AEP and pathological tau aggregation in locus coeruleus","volume":"130","author":"Kang","year":"2020","journal-title":"J Clin Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1073\/pnas.1220399110","article-title":"Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease","volume":"110","author":"Fitzmaurice","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neulet.2014.03.016","article-title":"Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein","volume":"569","author":"Jinsmaa","year":"2014","journal-title":"Neurosci Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF02260963","article-title":"The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis","volume":"7","author":"Enochs","year":"1994","journal-title":"J Neural Transm Park Dis Dement Sect."},{"key":"B39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/978-3-7091-9113-2_64","article-title":"Urinary dopamine sulfate: regulations and significance in neurological disorders","volume":"32","author":"Kienzl","year":"1990","journal-title":"J Neural Transm Suppl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.neulet.2009.12.025","article-title":"Trace amine metabolism in Parkinson's disease: low circulating levels of octopamine in early disease stages","volume":"469","author":"D'Andrea","year":"2010","journal-title":"Neurosci Lett."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/aws055","article-title":"Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies","volume":"135","author":"Goldstein","year":"2012","journal-title":"Brain."},{"key":"B42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10286-015-0268-z","article-title":"Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the Parkinsonian form of multiple system atrophy","volume":"25","author":"Goldstein","year":"2015","journal-title":"Clin Auton Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2016.07.009","article-title":"Elevated cerebrospinal fluid ratios of cysteinyl-dopamine\/3,4-dihydroxyphenylacetic acid in Parkinsonian synucleinopathies","volume":"31","author":"Goldstein","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0191670","DOI":"10.1371\/journal.pone.0191670","article-title":"Serum amino acid profile in patients with Parkinson's disease","volume":"13","author":"Figura","year":"2018","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.parkreldis.2018.02.023","article-title":"Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease","volume":"50","author":"Goldstein","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.32607\/20758251-2019-11-4-99-103","article-title":"Tear fluid catecholamines as biomarkers of the Parkinson's disease: a clinical and experimental study","volume":"11","author":"Kim","year":"2019","journal-title":"Acta Nat."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1038\/s41598-019-42535-w","article-title":"Different circulating trace amine profiles in de novo and treated Parkinson's disease patients","volume":"9","author":"D'Andrea","year":"2019","journal-title":"Sci Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/JPD-171228","article-title":"Monoaminergic markers across the cognitive spectrum of Lewy body disease","volume":"8","author":"van der Zee","year":"2018","journal-title":"J Parkinsons Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.dadm.2018.01.002","article-title":"Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with lewy bodies differential diagnosis","volume":"10","author":"Janssens","year":"2018","journal-title":"Alzheimers Dement (Amst)."},{"key":"B50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0165-1781(94)90046-9","article-title":"CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments","volume":"51","author":"Sharma","year":"1994","journal-title":"Psychiatry Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2174\/1570159X14666151230124904","article-title":"Drug delivery systems for imaging and therapy of Parkinson's disease","volume":"4","author":"Gunay","year":"2016","journal-title":"Curr Neuropharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","article-title":"Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles","volume":"16","author":"Gyorgy","year":"2011","journal-title":"Cell Mol Life Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"9","author":"Sun","year":"2010","journal-title":"Mol Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"7","author":"Tian","year":"2014","journal-title":"Biomaterials."},{"key":"B55","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"3","author":"Kim","year":"2016","journal-title":"Nanomedicine."},{"key":"B56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12264-016-0092-z","article-title":"Exosomes in Parkinson's disease","volume":"33","author":"Wu","year":"2017","journal-title":"Neurosci Bull."},{"key":"B57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pneurobio.2016.03.004","article-title":"Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications","volume":"151","author":"De","year":"2017","journal-title":"Prog Neurobiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"323686","DOI":"10.1155\/2012\/323686","article-title":"Imbalanced dopaminergic transmission mediated by serotonergic neurons in L-DOPA-induced dyskinesia","volume":"2012","author":"Navailles","year":"2012","journal-title":"Parkinsons Dis"},{"key":"B59","first-page":"217","article-title":"Exosomes-associated neurodegeneration and progression of Parkinson's disease","volume":"1","author":"Russo","year":"2012","journal-title":"Am J Neurodegener Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/hmg\/ddr606","article-title":"PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity","volume":"21","author":"Ramonet","year":"2012","journal-title":"Hum Mol Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/08923973.2019.1650371","article-title":"The multiple roles of exosomes in Parkinson's disease: an overview","volume":"4","author":"Porro","year":"2019","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J Control Release."},{"key":"B64","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1471-4159.2006.04241.x","article-title":"Dopamine and adult neurogenesis","volume":"3","author":"Borta","year":"2007","journal-title":"J Neurochem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/sctm.18-0162","article-title":"Intranasal administration of extracellular vesicles derived from human teeth stem cells improves motor symptoms and normalizes tyrosine hydroxylase expression in the substantia nigra and striatum of the 6-hydroxydopamine-treated rats","volume":"5","author":"Narbute","year":"2019","journal-title":"Stem Cells Transl Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1073\/pnas.0937635100","article-title":"SHED: stem cells from human exfoliated deciduous teeth","volume":"10","author":"Miura","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1172\/JCI59251","article-title":"Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms","volume":"1","author":"Sakai","year":"2012","journal-title":"J Clin Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12031-013-0046-0","article-title":"A new experimental model for neuronal and glial differentiation using stem cells derived from human exfoliated deciduous teeth","volume":"51","author":"Jarmalaviciute","year":"2013","journal-title":"J Mol Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/neu.2018.5898","article-title":"Neuronal enriched extracellular vesicle proteins as biomarkers for traumatic brain injury","volume":"36","author":"Karnati","year":"2019","journal-title":"J Neurotrauma."},{"key":"B70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fnmol.2018.00339","article-title":"Potential roles of microRNAs in the regulation of monoamine oxidase A in the brain","volume":"11","author":"Higuchi","year":"2018","journal-title":"Front Mol Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget."},{"key":"B72","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neurosci Lett."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.3390\/metabo7030042","article-title":"Biomarker research in Parkinson's disease using metabolite profiling","volume":"7","author":"Havelund","year":"2017","journal-title":"Metabolites."},{"key":"B74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuint.2019.04.015","article-title":"Sampling issues of cerebrospinal fluid and plasma monoamines: investigation of the circadian rhythm and rostrocaudal concentration gradient","volume":"128","author":"Janssens","year":"2019","journal-title":"Neurochem Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cca.2019.07.024","article-title":"Pre-analytical stability of novel cerebrospinal fluid biomarkers","volume":"497","author":"Willemse","year":"2019","journal-title":"Clin Chim Acta."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00595\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T04:17:39Z","timestamp":1594786659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00595\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":75,"alternative-id":["10.3389\/fneur.2020.00595"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00595","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]},"article-number":"595"}}